Neuropeptide Y (NPY): what it is and what the evidence says
One of the most abundant neuropeptides in the nervous system. It regulates appetite, energy balance, the stress response and anxiety depending on which receptor is activated.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
The brain adapts by forming and strengthening connections. Neurotransmitters take part in that conversation, along with factors that help neurons survive and grow. Compounds in this group are studied for their relationship with focus, memory, mood or neuroprotection — and it is worth saying plainly that this is the area where claims are most exaggerated and where human evidence is thinnest.
What it is studied for
A target for pharmacological research.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
Neuropeptide Y is one of the most abundant peptides in the human nervous system and a central regulator of appetite and stress. It is studied as a therapeutic TARGET, not as a substance to administer. No drug aimed at the NPY system has ever reached approval.
The limitation that matters most
The NPY system is functionally ambivalent: activating some receptors stimulates food intake while others reduce it. That is why administering exogenous NPY makes no therapeutic sense and could be counterproductive. It also crosses the blood-brain barrier poorly, so the central effects described come from intracerebral administration in animals.
Regulatory status
Not an approved or marketable product. An endogenous peptide and a research target.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
An ambivalent system: some receptors raise appetite and others lower it. Administering it makes no therapeutic sense.
Marked, sustained changes in appetite or anxiety belong in a psychiatric or endocrine consultation, where the whole stress axis can be examined properly.
What this page cannot give you
A reference page can take you this far. You know what Neuropeptide Y (NPY) is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Regulation of energy homeostasis by the NPY systemreview Trends Endocrinol Metab · 2015 · PMID 25662369 →
- Therapeutic potential of neuropeptide Y (NPY) receptor ligandsreview EMBO Mol Med · 2010 · PMID 20972986 →
- Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studiesreview Prog Neuropsychopharmacol Biol Psychiatry · 2021 · PMID 33991587 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Neuropeptide Y (NPY) or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is Neuropeptide Y (NPY)?
One of the most abundant neuropeptides in the nervous system. It regulates appetite, energy balance, the stress response and anxiety depending on which receptor is activated. It is studied within the area of cognitive.
Is there human evidence for Neuropeptide Y (NPY)?
Neuropeptide Y is one of the most abundant peptides in the human nervous system and a central regulator of appetite and stress. It is studied as a therapeutic TARGET, not as a substance to administer. No drug aimed at the NPY system has ever reached approval.
Is it approved by any health agency?
Not an approved or marketable product. An endogenous peptide and a research target.
What is the dose of Neuropeptide Y (NPY)?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what Neuropeptide Y (NPY) is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.